Current Affairs - October, 2020

Sudan becomes third Arab State to normalise relations with Israel.

Sudan recognized the Israel on October 23, 2020. It has became the third country to recognize Israel after UAE and Bahrain. Background The United States (US) recently made Israel, UAE and Bahrain to sign as agreement. Under the US-led agreement,  UAE and Bahrain agreed to recognise Israel as an independent state. To comply with the Read More…

Pakistan to remain in “Grey List” of FATF: Reason and implications.

The Financial Action Task Force (FATF) have voted to keep Pakistan under its Grey List.  The decision by the FATF was taken because Pakistan failed to comply with the 27 parameters set by the FATF and has completed only 21. Background The Asia-Pacific Group of FATF had also submitted a report called “Follow up report Read More…

PM launched the “Kisan Suryoday Yojana” in Gujarat.

Prime Minister Narendra Modi launched the Kisan Suryoday Yojana in Gujarat on October 24, 2020. The primary aim of the scheme is to provide day time power supply for irrigation in the region. Highlights Along with Kisan Suryoday scheme, PM Modi also launched two other projects namely, a ropeway at the Girnar in Junagadh district Read More…

Union Minister Jitendra Singh Addresses First Ministerial Meeting of G-20 Anti-Corruption Working Group.

Union Minister Jitendra Singh addressed the first ministerial meeting of G-20 anti-corruption working group on October 22, 2020. Saudi Arabia became the first country to host the first ever meeting.  Anti-Corruption Working Group of G-20 The was established in June 2010 at the G20 summit ,Toronto. The objective of the group is to make suggestions Read More…

Bharat Biotech’s Covaxin gets nod for Thrid phase clinical trial.

India’s indigenous COVID-19 vaccine candidate, COVAXIN, has received the nod for Phase-3 clinical trials in the country on October 23, 2020. The vaccine has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) . Key Facts The vaccine was given approval by the Subject Expert Committee which functions under Read More…